MedTrace Logo

Progestin-Only Pill Use and Breastfeeding Study

NCT04965116 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-04-19

Study results available
· View outcomes & findings →

Summary

This study will assess the impact of early initiation (less than one week postpartum) and delayed initiation (4 weeks postpartum) of two types of progestin-only contraceptive pills (POPs) on maternal, breastmilk, and infant outcomes.

Conditions

  • Contraception
  • Breastfeeding

Interventions

DRUG

Progestin Only Contraceptive Pills

Daily pill (placebo or active tablet)

Sponsors & Collaborators

Principal Investigators

  • Sarah Averbach, MD, MAS · University of California, San Diego

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-25
Primary Completion
2022-11-04
Completion
2022-11-04
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04965116 on ClinicalTrials.gov